Table 3.
Susceptibility to selected antibiotics, given as number of tested isolates susceptible to the given antibiotic/total number tested.
CoNS | S. aureus | Enterococci | Gram-negative | Streptococci | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Time period (years) | 93–97 | 98–02 | 03–07 | 93–97 | 98–02 | 03–07 | 93–97 | 98–02 | 03–07 | 93–97 | 98–02 | 03–07 | 93–97 | 98–02 | 03–07 |
| |||||||||||||||
Aminoglycosides | 10/19 | 13/26 | 14/45 | 5/5 | 8/8 | 22/22 | 0/8 | 0/2 | 3/10 | 4/4 | 7/8 | 11/11 | |||
Methicillin group | 12/28 | 15/33 | 10/62 | 10/10 | 15/15 | 37/37 | |||||||||
Cephalosporins, 3rd generation |
2/3 | 6/6 | 6/7 | ||||||||||||
Clindamycin | 23/29 | 17/31 | 34/64 | 11/11 | 13/13 | 35/36 | 2/2 | 6/6 | 10/13 | ||||||
Quinolones | 6/6 | 8/17 | 8/20 | 2/2 | 0/4 | 3/4 | 2/3 | 4/7 | 8/10 | ||||||
Carbapenems | 3/3 | 4/5 | 8/8 | ||||||||||||
Linezolid | 3/3 | 38/38 | 11/11 | 1/1 | 10/10 | ||||||||||
Rifampicin | 4/4 | 3/3 | 22/26 | 1/1 | 6/6 | ||||||||||
Fusidic acid | 12/29 | 14/31 | 33/63 | 11/11 | 13/14 | 33/35 | |||||||||
Macrolides | 16/20 | 9/22 | 29/57 | 7/7 | 11/12 | 32/33 | 3/3 | 5/6 | 8/11 | ||||||
Cotrimoxazole | 10/16 | 10/18 | 12/41 | 4/4 | 7/7 | 24/24 | 3/3 | 5/7 | 9/9 | ||||||
Ampicillin | 9/9 | 3/4 | 20/20 | 1/4 | 4/9 | 1/10 | |||||||||
Penicillin | 5/5 | 8/8 | 15/15 | ||||||||||||
Vancomycin | 26/26 | 23/23 | 51/51 | 8/8 | 7/7 | 10/10 | 6/6 | 3/3 | 15/15 |
CoNS = coagulase-negative staphylococci.